Why AbbVie Stock Popped While the Market Flopped on Monday

Yahoo Finance07:21

AbbVie Builds Momentum With Immunology Growth, Goldman Remains Positive

Benzinga02:13

Goldman Sachs Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $208

Futu News01:31 · Ratings

FDA Accepts Teva, Alvotech BLAs for Simponi Biosimilars

Seeking AlphaJan 27 23:59

Do Options Traders Know Something About AbbVie (ABBV) Stock We Don't?

Zacks Jan 27 21:30

Piper Sandler Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $227

Futu NewsJan 27 20:31 · Ratings